SAMHD1 and acute myeloid leukemia: Conversely, high SAMHD1 expression in acute myelogenous leukaemia patients is associated with efficacy reduction of the nucleoside-analogue anti-cancer drugs Cytarabine and Clofarabine32–34 as a result of SAMHD1 hydrolysis of their triphosphorylated forms35–38.